Streetbeat News

Regulatory

BTCUSD

COIN

Chris Senyek from Wolfe Research suggests that a Trump presidency could ease crypto regulations, benefiting Coinbase due to its significant Bitcoin leverage. Trump's potential participation in the Bitcoin 2024 convention could further impact the cryptocurrency market.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 8:14 am

REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi have received European Commission approval for Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD. This is the first global approval for Dupixent in COPD, with additional submissions under review in the U.S., China, and Japan.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 7:02 am

SPY

The S&P 500 has reached an all-time high, and wealth manager Ram Ahluwalia from Lumida Wealth predicts a bullish seasonality for the next two weeks. However, he warns of potential downside volatility following tech earnings and the Democratic National Convention. Ahluwalia also highlights the risk of market uncertainty if a new Democratic candidate emerges.

Portfolio Pulse from Shanthi Rexaline

July 03, 2024 | 5:55 am

MSFT

NVDA

Microsoft's $1 billion AI project with UAE's G42 in Kenya is under scrutiny due to national security concerns. The deal involves Microsoft investing $1.5 billion in G42, contingent on G42 severing ties with Chinese companies. However, Pentagon officials are skeptical about G42's complete disengagement from China. The scrutiny could impact the shipment of Nvidia's H100 chips to the Middle East and affect U.S. efforts to lead in AI development.

Portfolio Pulse from Ananya Gairola

July 03, 2024 | 3:48 am

AMZN

ANVS

LLY

PARA

TSLA

On Tuesday, the Dow Jones, S&P 500, and Nasdaq all closed higher. Tesla, Paramount Global, Annovis Bio, Eli Lilly, and Amazon were notable stocks. Tesla surged on strong deliveries, Paramount rose on takeover speculation, Annovis Bio soared on positive drug trial data, Eli Lilly fell due to political pressure on drug prices, and Amazon hit new highs on AI optimism.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 3:38 am

ETHUSD

Nate Geraci, president of The ETF Institute, suggests a potential mid-July launch for spot Ethereum ETFs, which could significantly impact the cryptocurrency market. The amended S-1s are due by July 8, with potential final S-1s by July 12, indicating a possible launch in the week of July 15. This could lead to substantial capital inflows and potentially increase Ethereum's value in U.S.-based spot ETFs.

Portfolio Pulse from Aniket Verma

July 03, 2024 | 2:44 am

BTCUSD

DOGEUSD

ETHUSD

Bitcoin and Ethereum experienced slight declines while Dogecoin saw a modest rise amid thin liquidity in the crypto market. Federal Reserve Chair Jerome Powell's dovish comments did not significantly impact investor sentiment. Bitcoin's open interest increased, indicating new short positions, which is seen as bearish. The global cryptocurrency market cap contracted by 0.35% in the last 24 hours.

Portfolio Pulse from Aniket Verma

July 03, 2024 | 1:49 am

JZXN

Trading for JZXN was halted at 7:50:00 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:50 pm

MDRR

Trading for the stock MDRR was halted at 7:50:00 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:50 pm

ASLN

Trading for ASLAN Pharmaceuticals (ASLN) was halted at 7:50:00 p.m. ET pending news. Investors should stay tuned for updates as trading halts often precede significant announcements.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:50 pm